| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.65B | — | +13.8% |
| Cost of Revenue | $864.1M | — | +0.1% |
| R&D Expense | $124.2M | — | +10.4% |
| SG&A Expense | $270.2M | — | +25.5% |
| Operating Income | -$5.3M | — | +81.5% |
| Pre-tax Income | $19.8M | — | +234.0% |
| Income Tax | $5.5M | — | +64.7% |
| Net Income | $14.3M | — | +455.1% |
| EPS (Basic) | $0.04 | — | +300.0% |
| EPS (Diluted) | $0.04 | — | +300.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.03B | -8.6% | +5.0% |
| Short-term Investments | $686.1M | -2.7% | -41.3% |
| Current Assets | $2.72B | -6.7% | -12.8% |
| Total Assets | $8.89B | -1.6% | +56.8% |
| Current Liabilities | $4.67B | +3.1% | +14.6% |
| Long-term Debt | $1.04B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $307.7M | — | +7.1% |
| Investing Cash Flow | $50.8M | — | -22.6% |
| Financing Cash Flow | -$366.6M | — | -609.2% |
| +6.4% |
| Total Liabilities | $5.86B | +1.9% | +21.4% |
| Stockholders' Equity | $3.03B | -7.6% | +261.0% |